Concepedia

Zhuyin Li

ZL

36

Publications

3.2K

Citations

26

H-Index

1988

Active since

Affiliations

National Institutes of Health(Current)

National Center for Advancing Translational Sciences

Bristol-Myers Squibb (United States)

University of Pennsylvania

National Cancer Institute

Zhuyin Li is an author at National Institutes of Health specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicineBiochemistryPharmacologyBioanalysisEngineeringDrug DiscoveryAnalytical ChemistryCardiologyCardiovascular DiseaseHigh-throughput Screening

Publications per year

1988–2021

36

Publications

36

Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors

Anju Singh, Sreedhar Venkannagari, Kyu Hee Oh et al. · ACS Chemical Biology · 2016 · 587 citations

Keap1-deficient Nsclc Tumors, Small Molecule Inhibitor, Cancer Biology +21

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction

Jordana B. Cohen, Sarah J. Schrauben, Lei Zhao et al. · JACC Heart Failure · 2020 · 376 citations · Full text

Heart Failure, Cardiovascular Disease, Medicine +2

Assay Guidance Manual [Internet]

Sarine Markossian, A Grossman, Kyle R. Brimacombe et al. · 2004 · 287 citations

Pharmaceutical Research, Drug Target, Biochemistry +15

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Julio A. Chirinos, Alena Orlenko, Lei Zhao et al. · Journal of the American College of Cardiology · 2020 · 200 citations · Full text

Heart Failure, Cardiovascular Disease, Cardiac Care +7

Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy

Hilary A. Kenny, Madhu Lal-Nag, Erin A. White et al. · Nature Communications · 2015 · 176 citations · Full text

Rows per page

1–5 of 36